UAE residents always welcome the onset of cool winter months, but there are some who suffer from seasonal ailments like ...

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS Pharmaceuticals, Inc. (“ARS Pharma”, NASDAQ: SPRY). The agreement grants ALK ...

Feeling stuffy and ready to reach for NyQuil, Benadryl, or Sudafed PE? Not so fast. The Food and Drug Administration has ...

Since Permatan doesn’t rely on the same controversial active ingredient as nasal sprays, it is considered to be safer in ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak ...

Medically reviewed by Daniel More, MD You can stop allergies with a variety of natural remedies, including breathing in steam ...

ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...

Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...